In Boost to Indigenous Vaccine Plan for Covid-19, Bharat Biotech Gets Clearance for Phase III Trial

[Spartan]

Covaxin, an indigenously developed vaccine candidate by Bharat Biotech, has got clearance for phase three trials in India. A top source said that the trials will start in the first week of November.

The source further said that 18-19 sites have been selected for the trial and over 22,000 volunteers have been selected. Bharat Biotech, in its report last month, had said that an animal study has shown its vaccine candidate has helped develop a strong immune response to the highly infectious coronavirus.

 

Covaxin is the first indigenous vaccine developed by India against Covid-19 and is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune.

ICMR and Bharat Biotech are jointly working for the preclinical as well as clinical development of this vaccine. Its trial for phase one and two was already underway after receiving the approval from Drugs Controller General of India (DCGI).

[Spartan]

Diwali roju release chesi..... Vijayam over Evil ani declare chestaremo...

@reality  @timmy  @Kool_SRG 

[Kool_SRG]

2 minutes ago, Spartan said:

Diwali roju release chesi..... Vijayam over Evil ani declare chestaremo...

@reality  @timmy  @Kool_SRG 

[Spartan]

@perugu_vada

[perugu_vada]

 anti-vacciners aina @Sucker uncle ki guchude soodhi tho India lo ki leg ettagane 

[Sucker]

21 minutes ago, perugu_vada said:

 anti-vacciners aina @Sucker uncle ki guchude soodhi tho India lo ki leg ettagane 

Vuncle Ind pothe shopping ke povali antha kanna panemundi Ind la